E-LIB Suche - Ergebnisse für: Nogami, Naoyuki

1

A single arm Phase I/II trial on the combination of carbopl..:

Nogami, Naoyuki ; Kubo, Toshio ; Bessho, Akihiro...
Japanese Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1093/..

2

Phase 1 study of pembrolizumab plus chemotherapy in Japanes..:

Nogami, Naoyuki ; Tokito, Takaaki ; Zenke, Yoshitaka...
Investigational New Drugs. 42 (2024) 1 - p. 136-144 , 2024

Link: https://doi.org/10.1007/..

3

Simple Symptom-Based Prediction of COVID-19: A Single-Cente..:

Inaba, Shinji ; Nakao, Yasuhisa ; Ikeda, Shuntaro...
Cureus. , 2023

Link: https://doi.org/10.7759/..

4

Effectiveness of Crizotinib in Patients withROS1-Positive N..:

Nogami, Naoyuki ; Nakamura, Atsushi ; Shiraiwa, Naoko...
Future Oncology. 19 (2023) 37 - p. 2453-2463 , 2023

Link: https://doi.org/10.2217/..

5

IMpower150 Final Exploratory Analyses for Atezolizumab Plus..:

Nogami, Naoyuki ; Barlesi, Fabrice ; Socinski, Mark A....
Journal of Thoracic Oncology. 17 (2022) 2 - p. 309-323 , 2022

Link: https://doi.org/10.1016/..

6

Pembrolizumab plus pemetrexed‐platinum for metastatic nonsq..:

Horinouchi, Hidehito ; Nogami, Naoyuki ; Saka, Hideo...
Cancer Science. 112 (2021) 8 - p. 3255-3265 , 2021

Link: https://doi.org/10.1111/..

7

Final survival results for the LURET phase II study of vand..:

Yoh, Kiyotaka ; Seto, Takashi ; Satouchi, Miyako...
Lung Cancer. 155 (2021) - p. 40-45 , 2021

Link: https://doi.org/10.1016/..

8

IMpower150 Final Overall Survival Analyses for Atezolizumab..:

Socinski, Mark A. ; Nishio, Makoto ; Jotte, Robert M....
Journal of Thoracic Oncology. 16 (2021) 11 - p. 1909-1924 , 2021

Link: https://doi.org/10.1016/..

9

Phase 1 study of pembrolizumab plus chemotherapy as first-l..:

Kurata, Takayasu ; Nakagawa, Kazuhiko ; Satouchi, Miyako...
Cancer Treatment and Research Communications. 29 (2021) - p. 100458 , 2021

Link: https://doi.org/10.1016/..

10

Survival of chemo-naïve patients with EGFR mutation-positiv..:

Ninomiya, Takashi ; Nogami, Naoyuki ; Kozuki, Toshiyuki...
Japanese Journal of Clinical Oncology. 51 (2021) 8 - p. 1269-1276 , 2021

Link: https://doi.org/10.1093/..

11

Five-year follow-up results from phase II studies of nivolu..:

Saka, Hideo ; Nishio, Makoto ; Hida, Toyoaki...
Japanese Journal of Clinical Oncology. 51 (2020) 1 - p. 106-113 , 2020

Link: https://doi.org/10.1093/..

12

Phase I/II study of carboplatin plus weekly nab-paclitaxel ..:

Zenke, Yoshitaka ; Niho, Seiji ; Umemura, Shigeki...
Lung Cancer. 146 (2020) - p. 182-188 , 2020

Link: https://doi.org/10.1016/..

13

A Phase 1 study of gefitinib combined with durvalumab in EG..:

Creelan, Benjamin C. ; Yeh, Tammie C. ; Kim, Sang-We...
British Journal of Cancer. 124 (2020) 2 - p. 383-390 , 2020

Link: https://doi.org/10.1038/..

14

Safety and efficacy of first‐line dacomitinib in Japanese p..:

Nishio, Makoto ; Kato, Terufumi ; Niho, Seiji...
Cancer Science. 111 (2020) 5 - p. 1724-1738 , 2020

Link: https://doi.org/10.1111/..

15

Lorlatinib in previously treated anaplastic lymphoma kinase..:

Seto, Takashi ; Hayashi, Hidetoshi ; Satouchi, Miyako...
Cancer Science. 111 (2020) 10 - p. 3726-3738 , 2020

Link: https://doi.org/10.1111/..